Background Metaplastic breast cancer (MBC) is characterized by various combinations of
adenocarcinoma, mesenchymal, and other epithelial components. It was officially …

Background Metaplastic breast cancer (MBC) is a rare histologic subtype needing further
characterization. The aim of our study was to compare MBC to infiltrating ductal carcinoma …

Abstract Objectives: Metaplastic breast carcinomas (MBCs) are rare, aggressive cancers
lacking targeted therapy. Here, we review the clinicopathologic features, treatment, and …

Background Metaplastic breast cancer is a rare disease with little information available to
guide therapy. The goals of this study were to describe the patient characteristics, systemic …

Metaplastic carcinoma of the breast (MCB) is a rare subtype of breast cancer. Anecdotal
reports are available regarding its response to systemic chemotherapy. We reviewed the …

Introduction Metaplastic breast cancer (MBC) is a rare condition of breast tumor with different
subtypes, considered a disease with worse prognosis; treatments and survival are often …

Purpose Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer, with
limited data available regarding treatment and outcomes. This study aims to review patients …

Aims The prognosis of metaplastic breast cancer (MBC) is reportedly worse than that of triple-
negative invasive ductal carcinoma (TN-IDC), but the determinants of poor prognosis are not …

Metaplastic breast cancer (MBC) is a rare subtype of invasive breast cancer that tends to
have an aggressive clinical presentation as well as a variety of distinct histologic …

Metaplastic breast carcinoma (MBC) is a rare, heterogeneous breast cancer characterized
by admixture of adenocarcinoma with metaplastic elements, low hormone receptor …